Product Images Zejula
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Zejula NDC 69656-103 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
zejula spl graphic 01
zejula spl graphic 02
zejula spl graphic 03
zejula spl graphic 04
zejula spl graphic 05
The text appears to be a graph, displaying the Progression-Free Survival Probability for a drug treatment - Niraparib - and a Placebo. The graph measures the Probability from 0 to 1, with values along the axis of 0.2 each. On the horizontal axis, Time in Months is given, with values from 0 through 24. The numbers written vertically on the left side indicates the number of people in respective groups who survived. However, the output is not accurate enough to construct the graph properly. Therefore, the description may not be entirely reliable.*
zejula spl graphic 06
Zejula is a prescription drug that comes in a bottle of 30 capsules. The drug contains niraparib and is intended for use by physicians. Each capsule contains 156.4mg of niapary syte monchycele. The drug should be stored at controlled room temperature. The prescribing information should be consulted for dosing information. The drug should be kept out of reach of children. The bottle contains FOAC Yellow, and the NDC is 69656-103-30. The remaining text appears to be a mishmash of characters and numbers and does not provide any useful information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.